Empowering innovation' Ensuring Trust
Dedicated to Oncology, Rare Diseases & Reproductive health
Oncology
Diagnostics, Therapeutics & Prognostic markers for various cancers.
Rare Diseases
Comprehensive test menu for rare disease diagnosis & management
Reproductive health
Most advanced test offerings in Reproductive genetics.
Infectious Diseases
Highly sensitive molecular testing in the infectious disease diagnosis.
Portfolio of 500+ Genomics Tests
Genetic Insights
with International Guidelines, clear & actionable results.
Genomic Instability status measured by Loss of Heterozygosity, (LOH), Telomeric Allelic Imbalance (TAI), and Large-Scale state Transitions (LST).
State of the art Technologies
Equipped with latest technologies in genomics including Next Generation Sequencers, Microarray systems, Droplet Digital PCR, Real Time PCRs, Automated karyotyping etc…
Team
Backed by strong management team, We are present in Bangalor & sales team presence through out south India.
PGT-M (Monogenic/ Single Gene Disorders-PGD) & PGT-A (Aneuploidy-PGS) is an early genetic diagnosis test for embryos produced during IVF, prior to their transfer to the uterus.
State of the art Technologies
Equipped with latest technologies in genomics including Next Generation Sequencers, Microarray systems, Droplet Digital PCR, Real Time PCRs, Automated karyotyping etc…
Team
Backed by strong management team, We are present in Bangalore & sales team presence through out south India.
Noninvasive prenatal testing (NIPT) analyzes cell-free DNA from a maternal blood sample to screen for common chromosomal conditions.
State of the art Technologies
Equipped with latest technologies in genomics including Next Generation Sequencers, Microarray systems, Droplet Digital PCR, Real Time PCRs, Automated karyotyping etc…
Team
Backed by strong management team, We are present in Bangalore & sales team presence through out south India.
Comprehensive test menu for Cell Free Total Nucleic acid analysis through DDPCR & NGS based assays.
State of the art Technologies
Equipped with latest technologies in genomics including Next Generation Sequencers, Microarray systems, Droplet Digital PCR, Real Time PCRs, Automated karyotyping etc…
Team
Backed by strong management team, We are present in Bangalore & sales team presence through out south India..
Human whole Genome Sequencing, provides Physicians, Researchers & Patients the clearest picture of the genome by sequencing the 3 billion nucleotides that compose the human genome.
State of the art Technologies
Equipped with latest technologies in genomics including Next Generation Sequencers, Microarray systems, Droplet Digital PCR, Real Time PCRs, Automated karyotyping etc…
Team
Backed by strong management team, We are present in Bangalore & sales team presence through out south India.
Whole Exome Sequencing (WES) sequences the complete actionable coding region of the genome. Designed to examine all the coding regions and splice junctions of the genome.
State of the art Technologies
Equipped with latest technologies in genomics including Next Generation Sequencers, Microarray systems, Droplet Digital PCR, Real Time PCRs, Automated karyotyping etc…
Team
Backed by strong management team, We are present in Bangalore & sales team presence through out south India.
Clinical exome sequencing (CES), sequences approx 7000 genes that are know to be disease associated and curated from databases such as OMIM, HGMD and ClinVar.
State of the art Technologies
Equipped with latest technologies in genomics including Next Generation Sequencers, Microarray systems, Droplet Digital PCR, Real Time PCRs, Automated karyotyping etc…
Team
Backed by strong management team, We are present in Bangalore & sales team presence through out south India.
A comprehensive menu of tests offered to understand the genetic basis of leukemias for Diagnostics, Therapeutics and Prognostics. NGS, DDPCR, Real Time PCR, Cytogenomics assays are offered to better understand the Hematological Malignancies.
State of the art Technologies
Equipped with latest technologies in genomics including Next Generation Sequencers, Microarray systems, Droplet Digital PCR, Real Time PCRs, Automated karyotyping etc…
Team
Backed by strong management team, We are present in Bangalore & sales team presence through out south India.
Wide range of NGS, Microarray, Karyotying, FISH, Real time PCR tests on solid tumor cancers including Lung cancer, Breast cancer, Sarcoma, Ovarian cancer, Prostate cancer, Thyroid cancer, Colorectal cancer, Gastrointestinal Stromal Tumor, etc...
State of the art Technologies
Equipped with latest technologies in genomics including Next Generation Sequencers, Microarray systems, Droplet Digital PCR, Real Time PCRs, Automated karyotyping etc…
Team
Backed by strong management team, We are present in Bangalore & sales team presence through out south India.
Comprehensive Hereditary Cancer Panel- For identification of germline mutations in 154 genes including BRCA1, BRCA2.
State of the art Technologies
Equipped with latest technologies in genomics including Next Generation Sequencers, Microarray systems, Droplet Digital PCR, Real Time PCRs, Automated karyotyping etc…
Team
Backed by strong management team, We are present in Bangalore & sales team presence through out south India.
OUR MISSION
"Rophevac Biolabz is dedicated to revolutionizing healthcare through precise diagnostics and groundbreaking research. Our mission is to provide accessible, state-of-the-art diagnostic services, enhancing patient care worldwide. By pushing the boundaries of medical knowledge and innovation, we aim to contribute to the advancement of healthcare for all, improving lives and shaping a healthier future."
OUR VISION
"Rophevac Biolabz envisions a healthcare landscape where excellence in diagnostics and
pioneering research uplifts medical care for all. Our commitment is to deliver the utmost
standard of service, ensuring accuracy and innovation in diagnostics. Through our
dedication to advancing medical research, we strive to contribute significantly to global
healthcare, fostering a healthier world for everyone."